173 related articles for article (PubMed ID: 22640485)
1. Oncolytic adenovirus armed with IL-24 inhibits the growth of breast cancer in vitro and in vivo.
Zhu W; Wei L; Zhang H; Chen J; Qin X
J Exp Clin Cancer Res; 2012 May; 31(1):51. PubMed ID: 22640485
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial strategies based on CRAd-IL24 and CRAd-ING4 virotherapy with anti-angiogenesis treatment for ovarian cancer.
Ashshi AM; El-Shemi AG; Dmitriev IP; Kashentseva EA; Curiel DT
J Ovarian Res; 2016 Jun; 9(1):38. PubMed ID: 27349517
[TBL] [Abstract][Full Text] [Related]
3. The antitumor efficacy of IL-24 mediated by E1A and E1B triple regulated oncolytic adenovirus.
Xiao LL; Wu YM; Qian J; Tan Y; Xie GL; Zhang KJ; Wang YG; Jia XY; Liu XY
Cancer Biol Ther; 2010 Aug; 10(3):242-50. PubMed ID: 20574150
[TBL] [Abstract][Full Text] [Related]
4. Novel Combination Oncolytic Adenoviral Gene Therapy Armed with Dm-dNK and CD40L for Breast Cancer.
Wang Q; Yang M; Zhang Y; Zhong L; Zheng X
Curr Gene Ther; 2019; 19(1):54-65. PubMed ID: 30848201
[TBL] [Abstract][Full Text] [Related]
5. An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer.
Zhong S; Yu D; Wang Y; Qiu S; Wu S; Liu XY
Acta Oncol; 2010; 49(1):91-9. PubMed ID: 19734998
[TBL] [Abstract][Full Text] [Related]
6. Systemic administration of mesenchymal stem cells loaded with a novel oncolytic adenovirus carrying IL-24/endostatin enhances glioma therapy.
Zhang J; Chen H; Chen C; Liu H; He Y; Zhao J; Yang P; Mao Q; Xia H
Cancer Lett; 2021 Jul; 509():26-38. PubMed ID: 33819529
[TBL] [Abstract][Full Text] [Related]
7. Potent antitumoral effects of targeted promoter-driven oncolytic adenovirus armed with Dm-dNK for breast cancer in vitro and in vivo.
Dong X; Qu W; Ma S; Zhu Z; Zheng C; He A; Karlsson A; Xu K; Zheng X
Cancer Lett; 2013 Jan; 328(1):95-103. PubMed ID: 23000515
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic adenovirus SG600-IL24 selectively kills hepatocellular carcinoma cell lines.
Xue XB; Xiao CW; Zhang H; Lu AG; Gao W; Zhou ZQ; Guo XL; Zhong MA; Yang Y; Wang CJ
World J Gastroenterol; 2010 Oct; 16(37):4677-84. PubMed ID: 20872968
[TBL] [Abstract][Full Text] [Related]
9. CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.
Kaliberova LN; Krendelchtchikova V; Harmon DK; Stockard CR; Petersen AS; Markert JM; Gillespie GY; Grizzle WE; Buchsbaum DJ; Kaliberov SA
Cancer Gene Ther; 2009 Oct; 16(10):794-805. PubMed ID: 19363468
[TBL] [Abstract][Full Text] [Related]
10. Conditionally replicative adenovirus-based mda-7/IL-24 expression enhances sensitivity of colon cancer cells to 5-fluorouracil and doxorubicin.
Xu J; Mo Y; Wang X; Liu J; Zhang X; Wang J; Hu L; Yang C; Chen L; Wang Y
J Gastroenterol; 2013 Feb; 48(2):203-13. PubMed ID: 22820863
[TBL] [Abstract][Full Text] [Related]
11. HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy.
Xu HN; Huang WD; Cai Y; Ding M; Gu JF; Wei N; Sun LY; Cao X; Li HG; Zhang KJ; Liu XR; Liu XY
Mol Cancer; 2011 Nov; 10():133. PubMed ID: 22040050
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic adenovirus‑mediated mda‑7/IL‑24 expression suppresses osteosarcoma growth and enhances sensitivity to doxorubicin.
Liu Z; Xu L; Yuan H; Zhang Y; Zhang X; Zhao D
Mol Med Rep; 2015 Oct; 12(4):6358-64. PubMed ID: 26251997
[TBL] [Abstract][Full Text] [Related]
13. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.
El-Shemi AG; Ashshi AM; Na Y; Li Y; Basalamah M; Al-Allaf FA; Oh E; Jung BK; Yun CO
J Exp Clin Cancer Res; 2016 May; 35():74. PubMed ID: 27154307
[TBL] [Abstract][Full Text] [Related]
14. Development of oncolytic adenovirus armed with a fusion of soluble transforming growth factor-beta receptor II and human immunoglobulin Fc for breast cancer therapy.
Seth P; Wang ZG; Pister A; Zafar MB; Kim S; Guise T; Wakefield L
Hum Gene Ther; 2006 Nov; 17(11):1152-60. PubMed ID: 17032151
[TBL] [Abstract][Full Text] [Related]
15. Oncolytic adenovirus encoding tumor necrosis factor-related apoptosis inducing ligand (TRAIL) inhibits the growth and metastasis of triple-negative breast cancer.
Zhu W; Zhang H; Shi Y; Song M; Zhu B; Wei L
Cancer Biol Ther; 2013 Nov; 14(11):1016-23. PubMed ID: 24025362
[TBL] [Abstract][Full Text] [Related]
16. Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL.
Liu X; Cao X; Wei R; Cai Y; Li H; Gui J; Zhong D; Liu XY; Huang K
Cancer Gene Ther; 2012 Jan; 19(1):49-57. PubMed ID: 21979578
[TBL] [Abstract][Full Text] [Related]
17. CD47-retargeted oncolytic adenovirus armed with melanoma differentiation-associated gene-7/interleukin-24 suppresses in vivo leukemia cell growth.
Li G; Wu H; Cui L; Gao Y; Chen L; Li X; Liang T; Yang X; Cheng J; Luo J
Oncotarget; 2015 Dec; 6(41):43496-507. PubMed ID: 26554307
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic Adenovirus rAd.DCN Inhibits Breast Tumor Growth and Lung Metastasis in an Immune-Competent Orthotopic Xenograft Model.
Zhao H; Wang H; Kong F; Xu W; Wang T; Xiao F; Wang L; Huang D; Seth P; Yang Y; Wang H
Hum Gene Ther; 2019 Feb; 30(2):197-210. PubMed ID: 30032645
[TBL] [Abstract][Full Text] [Related]
19. Systemic delivery of a novel liver-detargeted oncolytic adenovirus causes reduced liver toxicity but maintains the antitumor response in a breast cancer bone metastasis model.
Zhang Z; Krimmel J; Zhang Z; Hu Z; Seth P
Hum Gene Ther; 2011 Sep; 22(9):1137-42. PubMed ID: 21480822
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z
Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
